Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Toxicol Lett ; 271: 38-49, 2017 Apr 05.
Artigo em Inglês | MEDLINE | ID: mdl-28242422

RESUMO

Perfluorooctane sulfonyl fluoride (POSF) was a volatile starting material in the production of perfluorooctane sulfonate (PFOS), a stable surfactant that has been extensively studied due to its ubiquitous environmental distribution and slow clearance in humans. Because the inhalation toxicity of POSF on repeated exposure has not been previously reported, the current study evaluated the inhalation toxicity of POSF at 30, 100, and 300ppm (v/v) in rats for up to 13 weeks with a four-week recovery period. The extent of PFOS formation was also measured because POSF hydrolyzed to form PFOS. In addition, detailed urinalysis and examination of the urinary bladder were included to determine if factors associated with the development of bladder cancer were present. Exposure to POSF at 300ppm was associated with reduction in body weight-gain, necrosis of laryngeal cartilage, increased lung and bronchi weight with septal thickening, and changes in alveolar macrophages. The microscopic observations in larynx and lung are consistent with likely hydrolysis of POSF to form hydrogen fluoride (HF). Exposure to POSF at 100 and 300ppm was associated with increased relative liver weight, hepatocellular hypertrophy (except for females exposed to 100ppm POSF), and lowering of serum cholesterol (male only). After 13 weeks of exposure to 30, 100, or 300ppm POSF, serum PFOS concentration approximated 7, 35, or 100µg/mL, respectively. Approximately 0.1% of inhaled POSF was converted to PFOS. No changes indicative of bladder effects were observed in these rats exposed to POSF at any dose.


Assuntos
Poluentes Ambientais/toxicidade , Fluorocarbonos/química , Fluorocarbonos/toxicidade , Exposição por Inalação , Ácidos Alcanossulfônicos/metabolismo , Ácidos Alcanossulfônicos/toxicidade , Animais , Doença Hepática Induzida por Substâncias e Drogas/etiologia , Doença Hepática Induzida por Substâncias e Drogas/metabolismo , Doença Hepática Induzida por Substâncias e Drogas/patologia , Colesterol/sangue , Ingestão de Alimentos/efeitos dos fármacos , Poluentes Ambientais/sangue , Poluentes Ambientais/farmacocinética , Poluentes Ambientais/urina , Feminino , Fluorocarbonos/sangue , Fluorocarbonos/metabolismo , Fluorocarbonos/farmacocinética , Fluorocarbonos/urina , Ácido Fluorídrico/metabolismo , Ácido Fluorídrico/toxicidade , Hidrólise , Hipertrofia , Cartilagens Laríngeas/efeitos dos fármacos , Cartilagens Laríngeas/metabolismo , Fígado/efeitos dos fármacos , Fígado/metabolismo , Fígado/patologia , Pulmão/efeitos dos fármacos , Pulmão/patologia , Macrófagos Alveolares/efeitos dos fármacos , Macrófagos Alveolares/patologia , Masculino , Necrose , Tamanho do Órgão , Ratos Sprague-Dawley , Medição de Risco , Fatores de Tempo , Testes de Toxicidade , Aumento de Peso/efeitos dos fármacos
2.
J Laryngol Otol ; 111(8): 763-5, 1997 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-9327019

RESUMO

Post-radiation necrosis of the larynx is a major complication after irradiation and has become rare. Recently, combined chemotherapy and radiation therapy has been introduced for head and neck tumours. The authors report a case of laryngeal necrosis after combination therapy for a patient with cervical lymph node metastases of nasopharyngeal carcinoma and review the literature on late laryngeal necrosis. Although radiation-induced laryngeal necrosis has become a rare complication, the combination of chemotherapy and radiation therapy may increase its incidence. We should always consider it as a possible late complication and treat it appropriately.


Assuntos
Cartilagens Laríngeas/patologia , Radioterapia/efeitos adversos , Idoso , Carcinoma de Células Escamosas/tratamento farmacológico , Carcinoma de Células Escamosas/radioterapia , Terapia Combinada , Humanos , Cartilagens Laríngeas/efeitos dos fármacos , Cartilagens Laríngeas/efeitos da radiação , Masculino , Neoplasias Nasofaríngeas/tratamento farmacológico , Neoplasias Nasofaríngeas/radioterapia , Lesões por Radiação/patologia , Fatores de Tempo
3.
Ann Otol Rhinol Laryngol ; 96(4): 468-71, 1987.
Artigo em Inglês | MEDLINE | ID: mdl-3619294

RESUMO

The larynges of 30 unmated, mature female albino mice were examined histologically and histochemically after injecting them with 19-nandrolone phenylpropionate. Permanent irreversible changes, in the form of parakeratosis and squamous metaplasia of the epithelium, and hypertrophy of the muscle fibers, were observed together with persistence of increased alkaline phosphatase enzyme intensity in the endothelium of capillaries and increased activity of nonspecific esterase in the muscles. Similar changes may be responsible for the alteration in the human female's voice after prolonged treatment with anabolic steroids.


Assuntos
Anabolizantes/farmacologia , Laringe/efeitos dos fármacos , Animais , Feminino , Hiperplasia , Hipertrofia , Cartilagens Laríngeas/efeitos dos fármacos , Músculos Laríngeos/efeitos dos fármacos , Músculos Laríngeos/patologia , Laringe/patologia , Camundongos , Nandrolona/análogos & derivados , Nandrolona/farmacologia
4.
Anaesth Intensive Care ; 11(1): 47-51, 1983 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-6859509

RESUMO

The laryngeal mucosa of cats which had been treated with a lignocaine aerosol spray prior to endotracheal intubation was examined histologically. A degree of oedema and cell damage was apparent. When one side of the larynx was sprayed before intubation and the other side protected in the same cat, cellular damage was greater on the side which received the lignocaine spray. In no cat were the changes considered severe enough to constitute a post-anaesthetic hazard.


Assuntos
Cartilagem Aritenoide/efeitos dos fármacos , Cartilagens Laríngeas/efeitos dos fármacos , Edema Laríngeo/induzido quimicamente , Mucosa Laríngea/efeitos dos fármacos , Laringe/efeitos dos fármacos , Lidocaína/administração & dosagem , Aerossóis , Anestesia Local/efeitos adversos , Animais , Cartilagem Aritenoide/patologia , Gatos , Epitélio/patologia , Intubação Intratraqueal , Mucosa Laríngea/patologia , Lidocaína/efeitos adversos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...